Next Article 
Molecular and Cellular Biology, December 2000, p. 9103-9112, Vol. 20, No. 24
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Genomic Targeting of Methylated DNA: Influence of Methylation
on Transcription, Replication, Chromatin Structure, and Histone
Acetylation
Dirk
Schübeler,1
Matthew
C.
Lorincz,1
Daniel M.
Cimbora,1,
Agnes
Telling,1
Yong-Quing
Feng,2
Eric E.
Bouhassira,2 and
Mark
Groudine1,3,*
Division of Basic Sciences, Fred Hutchinson
Cancer Research Center, Seattle, Washington
981091; Department of Radiation
Oncology, University of Washington School of Medicine, Seattle,
Washington 981953; and Division of
Hematology, Department of Medicine, Albert Einstein College of
Medicine, Bronx, New York 104612
Received 20 July 2000/Returned for modification 10 August
2000/Accepted 26 September 2000
 |
ABSTRACT |
We have developed a strategy to introduce in vitro-methylated DNA
into defined chromosomal locations. Using this system, we examined the
effects of methylation on transcription, chromatin structure, histone
acetylation, and replication timing by targeting methylated and
unmethylated constructs to marked genomic sites. At two sites, which
support stable expression from an unmethylated enhancer-reporter
construct, introduction of an in vitro-methylated but otherwise
identical construct results in specific changes in transgene
conformation and activity, including loss of the promoter DNase
I-hypersensitive site, localized hypoacetylation of histones H3 and H4
within the reporter gene, and a block to transcriptional initiation.
Insertion of methylated constructs does not alter the early replication
timing of the loci and does not result in de novo methylation of
flanking genomic sequences. Methylation at the promoter and gene is
stable over time, as is the repression of transcription. Surprisingly,
sequences within the enhancer are demethylated, the hypersensitive site
forms, and the enhancer is hyperacetylated. Nevertheless, the enhancer is unable to activate the methylated and hypoacetylated reporter. Our
findings suggest that CpG methylation represses transcription by
interfering with RNA polymerase initiation via a mechanism that
involves localized histone deacetylation. This repression is dominant
over a remodeled enhancer but neither results in nor requires
region-wide changes in DNA replication or chromatin structure.
 |
INTRODUCTION |
In vertebrates, methylation of DNA
occurs predominantly at the cytosine of CpG dinucleotides. This
reversible modification is required for mouse development
(33), plays an active role in X-chromosome inactivation and
imprinting (25), and may be involved in tissue-specific gene
repression (4) and in the silencing of parasitic sequences
(52). Dynamic changes in methylation have been implicated in
malignant transformation (26), and thus far two genetic
disorders have been correlated to defects in genes involved in
maintenance of methylation and methylation-induced repression
(18).
The predominant consequence of methylation is transcriptional
repression, which can be mediated either directly, by blocking the
binding of transcription factors to CpG containing binding sites
(23), or indirectly by proteins that specifically bind to
methylated DNA via a methyl-CpG-binding domain (MDB) (37). Recently, several MBD-containing proteins have been described (19), of which four have been implicated in transcriptional repression. These proteins are thought to modify chromatin structure by
recruiting histone deacetylase (HDAC) activity to methylated DNA,
resulting in a repressive nucleosomal structure (reviewed in references
1 and 43).
The repressive effect of methylation on a given gene depends on the
nature of its control elements (such as enhancer and promoter) (2), the density of methylated CpGs (21), the
protein environment of a given cell type, and the chromosomal context
of the gene, which can support or repress transcription. Thus, to
determine the consequences of methylation on gene activity, it is
important to compare unmethylated and methylated DNAs in the same
cellular system and at the same position in the genome. The
availability of methylases from bacteria permits the methylation of
plasmid DNA in vitro prior to transfer into vertebrate cells. Thus far, standard techniques of gene transfer involving injection or
transfection have been used to introduce such in vitro-methylated DNA
into cells to determine the effects of DNA methylation on expression and/or chromatin structure. Studies using this experimental approach have contributed much information to our current understanding of
methylation-induced repression. However, this approach is limited by
the non-chromosomal-chromatin structure and the absence of replication
in the case of the nonintegrated DNA and by the influences of copy
number and different integration site(s) on transcription of the
transgene(s) in the case of the stable transfections.
Here we show that in vitro-methylated DNA can be efficiently targeted
into defined genomic sites using Cre recombinase. In order to analyze
the mechanism of methylation-induced repression, as well as the
dynamics of the methylation pattern, we used this approach to compare
methylated and unmethylated DNA after insertion into the same
chromosomal position. We targeted two genomic loci, both of which
support expression from an unmethylated transgene (9), with
either a fully methylated construct or an unmethylated, but otherwise
identical control.
Our results suggest that DNA methylation at a genomic site permissive
for transcription is stably propagated and is sufficient to repress
transcription. This repression occurs in the absence of de novo
methylation of adjacent DNA and without a change in the early timing of
replication, suggesting that methylation does not result in a
widespread change in the structure of the locus. Furthermore, we show
that the enhancer becomes demethylated and remodeled but is not
sufficient to overcome the repression, which occurs at the level of
transcriptional initiation. Consistent with the model of HDAC
recruitment by methylated DNA (1), we observe
hypoacetylation of histones H3 and H4 at the methylated regions of the
transgene, implicating a localized histone deacetylation as the cause
of repression.
 |
MATERIALS AND METHODS |
Vectors and in vitro methylation.
The targeting plasmid
pL1HS2EGFP1L was constructed by standard methods; the complete sequence
is available on request. It contains L1 and 1L loxP sites as
defined previously (10) flanking a HS2 fragment of the human
-globin LCR (GenBank HUMHBB file 7764 to 9218) linked to the human
-globin promoter (fragment
374 to +44 relative to the cap site)
driving an enhanced green fluorescent protein (EGFP) reporter gene. The
EGFP reporter consist of the simian virus 40 (SV40) 16S-19S splicing
sites fused to the EGFP coding sequences (fragment
NcoI-NotI, positions 677 to 1401 of Clontech
[Palo Alto, Calif.] plasmid pEGFP-N1) and to SV40 polyadenylation
sites. The SV40 16S-19S splicing sites and the poly(A) signal were
derived from Clontech plasmid pCMVBeta. In vitro methylation was
performed with SssI methylase (NEB) according to the
protocol supplied by the manufacturer, followed by organic extraction
and ethanol precipitation. Completeness of reaction was verified by
full resistance to digestion with the methylation-sensitive enzymes
HpaII and HhaI.
Cell lines and gene targeting.
MEL cell clones RL5 and RL6
contain a HYTK fusion gene flanked by inverted loxP sites
(9). These cells were cultivated in Dulbecco's modified
Eagle's medium supplemented with 10% calf serum and split every 4 days. Prior to Cre-mediated targeting, cells were cultured in medium
supplemented with 750 µg of hygromycin (Roche) per ml to select cells
expressing the HYTK fusion gene. After selection, 4 × 106 cells were cotransfected with 25 µg of pL1HS2EGFP1L,
20 µg of Cre expression plasmid (CMV-Cre) (17), and 200 µg of sonicated salmon sperm DNA as a carrier in a BTX electroporator
set to 250 V and 1,100 µF. Cells were plated in nonselective media
and split after 3 days into media containing 10 µM ganciclovir to
select against HYTK-expressing cells. After 1 week in selection,
dilutions were plated to obtain single clones, which were then expanded and analyzed by genomic DNA Southern blot.
FACS analysis.
For GFP expression analysis, a single-cell
suspension was harvested and washed with staining media
(phosphate-buffered saline supplemented with 3% calf serum). Cells
were resuspended in staining media supplemented with 1 µg of
propidium iodide (PI) per ml for live-dead discrimination.
Fluorescence-activated cell sorter (FACS) analysis was carried out on a
FACSCalibur cytometer (Becton Dickinson) equipped with the standard
fluorescein filter set. Data on a minimum of 10,000 live cells were
collected and analyzed with the software CellQuest (Becton Dickinson).
Nuclease sensitivity analysis.
DNase I digestion of nuclei
and subsequent Southern blot analyses were performed as described
previously (11). The complete GFP coding region was used as
a probe.
Replication timing analysis.
Replication timing was analyzed
essentially as described elsewhere (7). Exponentially
growing cells were pulse-labeled with bromodeoxyuridine (BrdU) and
fixed. After being stained with PI, cells were sorted into different
phases of the cell cycle according to DNA content, and BrdU-containing
nascent DNA was purified by immunoprecipitation with an antibody
against BrdU-DNA (Becton Dickinson). PCR (23 cycles) was performed
using 2 µl (500 cell equivalents) of each nascent strand sample as a
template. Southern blots were prepared and probed with radiolabeled
probes synthesized by random priming the equivalent PCR product,
amplified separately from a clone containing the transgene. In each
experiment, genomic DNA from the same clone was included as a control
for the strength and specificity of the PCR. All primers were specific and yielded a single primary product.
Analysis of histone acetylation.
Chromatin fixation and
purification were performed as described earlier (46).
Exponentially growing cells (2 × 108) were fixed in
150 ml of Dulbecco's modified Eagle's medium with 1% formaldehyde
for 3 min at room temperature. After sonication, protein-DNA complexes
were purified by isopycnic centrifugation (40). DNA content
of cross-linked chromatin was quantified using a Hoefer Instruments
fluorometer. Polyclonal antibodies against all acetylated isoforms of
histone H4 (
H4-Ac) and against histone H3 acetylated at lysines 9 and 14 (
H3-Ac) were purchased from Upstate Biotechnology.
Immunoprecipitation conditions for both antisera were as described
elsewhere (46). Quantitative PCR of input and antibody-bound
chromatin was performed with 1 to 2 ng of DNA as a template in a total
volume of 25 µl with the appropriate primer pairs. Primers for
transgene sequences were designed and tested to be specific and to give
a product size ranging from 340 to 380 bp. The primer pair for the
mouse amylase gene (amy4+6) gives a product of 400 bp, allowing us to
perform duplex PCR with any of the transgene primer sets. A total of
0.1 µl of [
32P]dCTP (NEN) was added to each
reaction. For each sequence, PCR reactions were performed in parallel
under conditions of linear amplification (see Fig. 2 in reference
46; also data not shown) in a Perkin-Elmer 9600 thermocycler, for 27 cycles, using identical temperature profiles for
all primer pairs. One-third of the reaction was subjected to
electrophoresis on a 5% nondenaturing polyacrylamide gel, and products
were quantified with a PhosphorImager and the ImageQuant software
(Molecular Dynamics).
Nuclear run-on analysis.
Nuclear run-on assays were
performed as described earlier (31) using
[
-32P]CTP as the label. A 369-bp fragment, starting 47 bp downstream of the cap site and ending 170 bp into the GFP reading
frame was used as a promoter-proximal probe, generated by PCR using the primer pair roGFP1+2. The distal probe was generated with the primer
pair GFP1+2 and corresponds to the 3' half of the GFP gene (bp 232 to
611 of the reading frame).
Methylation analysis.
Southern blot analysis to detect the
methylation state of HpaII sites was carried out using
standard procedures. Bisulfite conversion was conducted as described
previously (34). To obtain the methylation status of the
enhancer, nested PCR of converted genomic DNA was carried out with
primer pairs +bisHS2-1 and
bisHS2-1 in the first round (30 cycles;
annealing temperature, 50°C) and +bisHS2-2 and
bisHS2-2 in the
second round of PCR (29 cycles; annealing temperature, 50°C). For the
promoter, primer pairs +bis
pr1 and
bis
pr1 (30 cycles;
annealing temperature, 50°C) and +bis
pr2 and
bis
pr1 (29 cycles; annealing temperature, 50°C) were used in the first and
second rounds, respectively. PCR products were cloned using the TA
Cloning Kit (Invitrogen, Carlsbad, Calif.), and individual clones were
sequenced with an ABI PRISM 377 DNA sequencer (Perkin-Elmer) as
described earlier (34).
Primer sequences.
Listed are the names, product sizes, and
sequences (in parentheses) of primers used in this study. The sequences
in the transgene were as follows: GFP1+2, 377 bp, GFP-1
(ACATGAAGCAGCACGACTTC) and GFP-2 (TGCTCAGGTAGTGGTTGTC);
roGFP1+2, 369 bp, roGFP-1 (ACCGGTGGTCGAGGAACTGA) and
roGFP-2 (AGGGCACGGGCAGCTTGC); hubPr1+5, 342 bp, hubPr-1
(TGCTTACCAAGCTGTGATTCC) and hubPr-5
(GTGTCTGTTTGAGGTTGCTAG); huHS21+4, 343 bp, huHS2-1 (TTCCAGCATCCTCATCTCTGA) and huHS2-4
(TTTAGTCAGGTGGTCAGCTTCTC); mouse amylase 2.1y gene amy4+6,
401 bp, Amy4 (TCAGTTGTAATTCTCCTTGTACGG) and Amy6
(CATTCCTTGGCAATATCAACC); amyl1+2, 370 bp, mAmyl1
(AGCACTGAGGATTCAGTCTATG) and mAmyl2,
(CCCGTACAAGGAGAATTACAAC); and mouse
-globin 5'Ey (located
1.1 kb 5' of the Ey start codon), 376 bp, 5Ey-3
(GCACATGGATGCAGTTAAACAC) and 5Ey-4
(GAGTGACAGTGTAGAGAAGATG). The primers for bisulfite converted DNA of the transgene were as follows: +bisHS2-1
(GTTATATTTTTGTGTGTTTTTATTAGTGAT), +bisHS2-2
(TATAGTTTAAGTATGAGTAGTTTTGGTTAG), +bisHS2-2
(TATAGTTTAAGTATGAGTAGTTTTGGTTAG),
bisHS2-2
(TACACATATATTAATAAAACCTAATTCTAC),
+bis
pr-1 (ATATGAAATAAGGATATGGAAGAGGAAGGT), +bis
pr-2 (TTTTAAGGTATTTTTGGATAGTTAGGTGGT), and
bis
pr-1 (CAAACCTAAAAATAAAAACAACATCCACTA).
 |
RESULTS |
Experimental strategy.
Our goal was to define the effects of
DNA methylation in a defined chromosomal position. To accomplish this,
we targeted control and in vitro-methylated DNA to the same sites in
the genome. The likely repressive effect of methylation on
transcription precluded the use of homologous or site-specific
recombination targeting strategies, which depend upon the expression of
a marker gene on the DNA molecule to be inserted. Instead, we made use
of recombinase-mediated cassette exchange (RMCE), which allows the
targeted insertion of a DNA cassette by selection against the HYTK
fusion gene introduced during the original derivation of the targeting
sites (10, 47).
We chose two genomic sites (RL5 and RL6) in mouse erythroleukemia (MEL)
cells which can be targeted with Cre-recombinase using RMCE (Fig.
1A
[9, 10]). A DNA
construct containing the HS2 enhancer element from the human
-globin
LCR, the human
-globin gene promoter, and the GFP reporter gene was
either left unmodified or in vitro-methylated with SssI
methylase (which methylates every CpG) and subsequently inserted into
these sites.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Principle of Cre-RMCE with inverted loxP
sites. First, a stable cell line is generated with a construct encoding
the positive-negative selectable marker gene HYTK (a fusion of
hygromycin B phosphotransferase and herpes simplex virus thymidine
kinase) flanked by inverted loxP sites. For the replacement
reaction, a construct containing a similar set of loxP sites
flanking the cassette to be recombined is transfected together with a
Cre recombinase expression plasmid. Recombination between the
loxP sites in the two constructs results in exchange of the
cassettes and loss of the TK-negative selectable marker. The inverted
loxP sites on the same DNA molecule can also recombine,
resulting in the inversion of the intervening DNA (10).
Ganciclovir is used to select against cells that still express the HYTK
gene, allowing isolation of cells that have undergone the targeting
reaction. (B) Representative Southern blot analysis of clones derived
from RL6 using a restriction enzyme and probe combination that allows
determination of the correct integration and orientation. Clones
containing the transgene exclusively in one orientation (lanes 1, 2, 4, 5, and 6) were further analyzed, a mixture of both orientations (lane
3), or additional random insertions of the targeting construct (lane 7)
were discarded. (C) Expression of the reporter gene, as measured by
flow cytometry, is independent of the time in culture and is repressed
by in vitro methylation. After targeted insertion into RL5 and RL6,
clones containing the unmethylated transgene (RL5-HS2 and RL6-HS2
[black]) or the in vitro-methylated transgene (RL5-HS2meth and
RL6-HS2meth [grey]) were analyzed by FACS either immediately after derivation (upper profile) or after an additional 10 weeks in culture (lower profile). The original RL5 and RL6 clones
(containing only the HYTK marker) served as a negative control (white).
The fluorescence values shown reflect the difference between the median
of the transgene containing clone and that of the GFP negative parental
clone.
|
|
Clones were derived and analyzed by Southern blotting for legitimate
exchange of the cassette as shown in Fig.
1B. RL5-HS2
and RL6-HS2 refer
to the unmethylated construct inserted into
RL5 and RL6, respectively,
and RL5-HS2meth and RL6-HS2meth refer
to the in vitro-methylated
constructs at these sites. The targeting
efficiency, measured as the
percentage of ganciclovir-resistant
clones that have been correctly
targeted, varied between 40 and
80% (data not shown). In vitro
methylation of the plasmid did
not decrease the targeting efficiency or
the total number of clones,
suggesting that CpG methylation does not
interfere with recombinase
activity. Thus, Cre-RMCE is suitable to
target in vitro-methylated
DNA into previously marked genomic
sites.
Methylation-induced repression in permissive genomic sites.
To
measure the effect of methylation on reporter gene expression, GFP
fluorescence was analyzed by flow cytometry. As shown in Fig. 1C, both
RL5 and RL6 insertion sites support pancellular GFP expression from the
unmethylated transgene at high levels. In contrast, at both genomic
sites, methylation of the reporter construct represses GFP expression
in all cells analyzed. At RL5, GFP expression from the methylated
construct is reduced to just above the background fluorescence level.
Analysis of steady-state RNA using Northern blot analysis revealed that
the residual GFP fluorescence reflects low-level transcription (data
not shown). A similar expression pattern for the unmethylated and in
vitro-methylated construct was observed at RL5 and RL6 when the
transgene was integrated in the opposite orientation, indicating that
in both genomic sites these expression characteristics are not
orientation dependent (data not shown). The repressed and active
expression states of the methylated and unmethylated transgenes,
respectively, are stable over at least 12 weeks in culture,
corresponding to ca. 100 cell divisions (Fig. 1C). The expression
status at the RL5 integration site did not change even after 10 months
in culture, whereas at RL6 noticeable silencing of the unmethylated
transgene was observed in one orientation by the fourth month of
culture, as described elsewhere (9).
Maintenance of methylation.
The stable expression states of
the unmethylated and premethylated transgenes at RL5, even after
extended periods in culture, suggest that the original methylation
state is propagated in vivo. To determine if the methylation state of
the introduced cassette is faithfully maintained, genomic DNA was
isolated immediately after clone derivation (day 14) and after an
additional 10 weeks in culture (day 90). First, the extent of
methylation of the transgene and the adjacent genomic sequence was
characterized by Southern blotting using the methylation-sensitive
restriction enzyme HpaII. The position of each restriction
site and the DNA fragment used as a probe are shown in Fig.
2A. The HpaII sites in the GFP
gene of the unmethylated construct at RL5 (RL5-HS2) are susceptible to
digestion at the early and late time points, suggesting that no de novo
methylation has occurred. In contrast, digestion of the RL5-HS2meth
clone yields a larger fragment, indicating that these sites are
methylated. The XbaI/HpaII digest reveals that all nine HpaII sites in the promoter and the GFP gene are
blocked, suggesting that this part of the transgene remains completely methylated. However, the resulting fragment is smaller than a fragment
obtained with the XbaI digest alone, indicating that digestion occurs at an endogenous, unmethylated HpaII site
outside of the transgene. Thus methylation is stably maintained in this part of the transgene, and we find no evidence for de novo methylation at one CpG in the flanking genomic DNA.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
Maintenance of the methylation status. (A) Map of the
L1-HS2GFP-1L transgene, including locations of the HpaII
(black diamonds) XbaI (X), BglII (B), and
loxP sites (black triangles). For Southern blot analyses,
genomic DNA from the early and late time points was digested with
either XbaI or BglII, in combination with the
methylation-sensitive enzyme HpaII, and hybridized with a
GFP probe (black bar). The unmethylated clone RL5-HS2 yields a 600-bp
fragment with both HpaII-containing digests at both time
points, indicating that no de novo methylation of the GFP gene has
occurred. The in vitro-methylated clone RL5-HS2meth shows methylation
of all HpaII sites in the transgene, with the exception of
the three HpaII sites at the 5' end of the transgene, as
indicated by the 2.4-kb fragment obtained with a
BglII/HpaII digest (see the text). (B) Detailed
mapping of the methylation status of the enhancer and promoter region.
Genomic DNA from the late time point was bisulfite converted, and the
sequences of interest were PCR amplified, subcloned, and sequenced (see
Materials and Methods). The positions of primers are indicated by open
triangles. Open or filled circles correspond to unmethylated or
methylated CpGs, respectively.
|
|
The
BglII/
HpaII restriction digest reveals the
methylation status of the GFP gene, promoter, enhancer, and 5'-flanking
genomic
DNA (Fig.
2A). This digest yields a 2.4-kb fragment in case of
RL5-HS2meth, which is indicative of methylation of all eight
HpaII
sites in the coding region and promoter but
demethylation of a
HpaII site in the enhancer. This site is
partially demethylated
at the early time point and fully demethylated
after 10 weeks
in
culture.
To further characterize the extent of demethylation in this region, we
mapped the methylation state of all CpGs in the enhancer
and promoter
region using bisulfite conversion and sequencing
(
34;
see also Materials and Methods). This technique allows
the analysis of
the methylation state of any cytosine, independent
of its sequence
context. Primers to PCR amplify the bisulfite-converted
genomic DNA
were chosen to be specific for the core of HS2 or
the promoter; the
resulting methylation data are shown in Fig.
2B. Consistent with the
Southern blot analysis, the promoter is
methylated in the RL5-HS2meth
clone, indicating that methylation
is maintained in this region.
However, the CpGs present in the
HS2 enhancer are unmethylated in both
RL5-HS2 and RL5-HS2meth,
the latter suggesting that demethylation of
the enhancer has occurred
in vivo (Fig.
2B).
In summary, the introduced methylation is stably maintained at the
promoter and coding region and no spreading of methylation
into
adjacent genomic DNA occurs. However, the enhancer is demethylated
in
the in vitro-methylated clone. Despite this demethylation,
the enhancer
is unable to overcome the methylation-induced
repression.
Early timing of replication in the methylated state.
Early
timing of DNA replication has been associated in many systems with
active transcription, open chromatin structure, and hypomethylation of
the DNA, whereas late replication has been correlated with
transcriptional inactivity, closed chromatin structure, and
hypermethylation (48). Thus, we sought to determine whether the targeted introduction of methylation affects the replication timing
at both integration sites (RL5 and RL6) by determining the relative
abundance of specific genomic sequences in nascent DNA synthesized
during different windows of the cell cycle (Fig. 3 and reference
7). Exponentially growing cells were pulse-labeled with
BrdU and sorted by FACS into different fractions of the cell cycle
based on their DNA content. BrdU-labeled DNA was enriched by
immunoprecipitation and analyzed by PCR, using primers specific for the
transgene or endogenous loci with a known timing of replication. As a
control for early replication, we used the endogenous mouse
-globin
locus and as a control for late replication we used the mouse amylase
2.1y gene, which we have shown previously to be late replicating in
erythroid cells (7). The unmethylated transgene in the clone
RL5-HS2 replicates early during S phase in comparison to the late
control and as early as the mouse
-globin locus (Fig. 3). The replication timing of the RL5
locus is also early in the methylated and transcriptionally repressed
clone RL5-HS2meth (Fig. 3), which is indistinguishable from the
unmethylated clone. At the RL6 locus we find the same result: early
timing of replication with both the unmethylated and the methylated
constructs (data not shown). Thus, at both genomic sites, methylation
of the transgene does not interfere with its early replication. We
conclude that the establishment of methylation-induced repression
neither requires nor results in late replication of these genomic
regions.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 3.
Replication timing of the RL5 insertion site containing
the unmethylated (RL5-HS2) and methylated transgene (RL5-HS2meth). (A)
Histograms of PI staining intensity (DNA content) of cells for timing
analysis are shown. The gates used to sort cells into fractions
corresponding approximately to G1, S phase (S1
to S4), and G2 are labeled. (B) PCR-Southern
analysis of replication timing of the transgene and control loci.
Analysis was performed as described in Materials and Methods, using
primers for the early-replicating control loci (endogenous murine
-globin [5'Ey3+4]), a late-replicating control locus (murine
amylase [mAmyl1+2]), and the transgene enhancer (huHS21+2) and
reporter gene (roGFP1+2). In RL5-HS2 and RL5-HS2meth, the transgene
replicates as early as the endogenous murine -globin locus,
indicating that methylation of the transgene does not delay its
replication timing.
|
|
Remodeling of the enhancer is not influenced by the local
methylation state.
Despite the localized demethylation of HS2
observed in the RL5-HS2meth transgene, the enhancer is unable to
activate transcription. Thus, we asked whether methylation of the
promoter and gene interferes with remodeling of the enhancer. Nuclei
were isolated and incubated with increasing amount of DNase I, and the
resulting genomic DNA was analyzed on a Southern blot. In the
unmethylated RL5-HS2 clone, we detect hypersensitive-site (HS)
formation at the
-promoter, at the HS2 enhancer and in addition, at
an endogenous site 5' of the transgene (Fig.
4A). In the transcriptionally repressed and methylated clone RL5-HS2meth, no HS forms at the promoter, while
the enhancer and the endogenous sites form as in the unmethylated control.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of enhancer and promoter remodeling. Nuclei
were isolated and digested with increasing concentrations of DNase I. Subsequently, genomic DNA was isolated, digested with Bgl
II, and hybridized with a probe corresponding to the GFP gene. (A)
Analysis of integration site RL5 with the unmethylated (RL5-HS2) and
methylated (RL5-HS2meth) transgene. (B) Analysis of integration site
RL6. Each hypersensitive site detected is marked with an arrow.
|
|
To test whether enhancer HS formation at the RL5 integration site is
influenced by the presence of the endogenous HS, a similar
DNase I
series was performed with the corresponding constructs
integrated at
RL6 which does not show an endogenous HS in proximity
to the 5' end of
the transgene. At this locus, both the promoter
and the enhancer HSs
form in the unmethylated and expressing clone,
whereas only the
enhancer HS is present in the methylated clone
(Fig.
4B). Thus, in both
genomic loci, the enhancer HS forms regardless
of the methylation state
of the downstream region. Since the formation
of an HS is a consequence
of non-histone protein binding (
3),
we conclude that the
enhancer sequence is accessible to transactivators,
even in close
proximity to the methylated promoter and
gene.
Methylation represses initiation of transcription.
Several
mechanisms have been proposed to explain how DNA methylation interferes
with the process of transcription. A study in the fungus
Neurospora crassa suggested that DNA methylation inhibits
RNA-polymerase elongation, whereas the loading of polymerases is not
disturbed (45). On the other hand, experiments in
Xenopus oocytes with nonreplicating plasmids suggested that
methylation blocks the loading of RNA-polymerase (29).
Genomic targeting of in vitro-methylated DNA allowed us to examine this
question in a mammalian system, with the advantage that the methylated and unmethylated constructs reside in the same chromosomal locus and in
a single copy.
To determine whether the methylated and unmethylated transgenes show
equivalent loading of polymerase, nuclear run-on assays
were performed
with nuclei isolated from RL5-HS2, RL5-HS2meth,
and the parental clone
RL5. In the run-on assay, elongation of
already-initiated transcript
proceeds in the presence of radiolabeled
CTP under conditions which
dissociate from DNA any nonpolymerase
protein which could interfere
with transcriptional elongation
(
16) (see Materials and
Methods). The resulting nuclear run-on
RNA(s) were analyzed by
hybridization to an endogenous control
and to sequences corresponding
to a promoter-proximal and distal
sequence of the reporter gene. As
shown in Fig.
5, the unmethylated
and
transcribing RL5-HS2 clone shows a strong promoter-proximal
signal and
a weaker promoter-distal signal. Both signals indicate
active
transcription, the difference in intensity between promoter-proximal
and distal probe suggests a higher density of polymerases at the
promoter than at the gene. This indicates a high degree of polymerase
loading and possible promoter-proximal pausing, as we and others
have
described previously for a number of endogenous genes and
synthetic
constructs (reviewed in reference
32). However, the
nuclear RNA from RL5-HS2meth shows no signal above background
for both
reporter gene probes, indicating that polymerase loading
is
significantly reduced in the methylated construct. Thus, in
a
chromosomal context in mammalian cells, methylation interferes
with
polymerase loading, as described previously in
Xenopus
oocytes.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 5.
Nuclear run-on analysis to determine the density of
polymerases in the unmethylated and methylated transgenes at the RL5
integration site. Nuclei from the RL5-HS2 clone, containing the
unmethylated transgene, the RL5-HS2meth clone, containing the
methylated transgene and the control parental clone RL5 without the
transgene were isolated. Nuclear run-on assays were performed in the
presence of radioactively labeled CTP, and nascent RNA was hybridized
to three different DNA probes: -actin as an endogenous control;
5'GFP, a promoter-proximal fragment containing the 3' end of the
-globin promoter and the 5' half of the GFP gene (a PCR product
generated with the primer pair roGFP1+2); and 3'GFP, a promoter-distal
fragment containing most of the 3' half of the GFP coding region
(generated with the primer pair GFP1+2). The actively expressing clone
RL5-HS2 yields a higher signal for the proximal than for the distal
probe, indicating that promoter-proximal pausing of polymerases occurs
(see the text). In contrast, RL5-HS2meth gives no signal above
background for either probes, suggesting a strong reduction of
polymerase loading in the methylated state.
|
|
Methylation density defines the level of histone acetylation.
Hyperacetylation of histones has been shown to mark open chromatin and
to be required for transcriptional activation (49). The
recent finding that MBD proteins interact with HDACs suggests that
methylation represses transcription by recruiting HDAC activity, resulting in hypoacetylation of histones residing in methylated DNA
(1). We measured the relative level of histone acetylation of the methylated and unmethylated transgenes integrated at the RL5
genomic site. Formaldehyde cross-linked chromatin was purified and
immunoprecipitated with antisera against acetylated isoforms of
histone H3 and H4, as described previously (46). The
antibody-bound DNA was analyzed with a duplex PCR approach using one
primer pair specific for a transgenic sequence and a second pair
specific for the endogenous amylase 2.1y gene, under conditions of
linear amplification (46; see also Materials and
Methods). This amylase gene is in a closed chromatin conformation and
is characterized by relative hypoacetylation of histones H3 and H4 in
MEL cells (46). The ratio of the two PCR products was
determined for the antibody-bound fraction and normalized to the ratio
obtained from the input material prior to immunoprecipitation. Three
different regions in the RL5-HS2 and RL5-HS2meth transgenes were
analyzed: the enhancer, the promoter, and the coding region of the
reporter gene. A representative set of PCR products and the resulting
enrichments relative to amylase are shown in Fig.
6A.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
Chromatin immunoprecipitation analysis of histone H3 and
H4 acetylation in different regions of the methylated and unmethylated
transgene. Antibodies recognizing all acetylated isoforms of H4 (H4) or
histone H3 acetylated at lysines 9 and 14 (H3) were used for
immunoprecipitation. PCRs were performed on the input and
antibody-bound chromatin fractions in the presence of a radiolabeled
nucleotide under conditions of linear amplifications, as we have shown
previously (see reference 46 and Materials and
Methods). One primer pair amplifies a sequence from the transgene and
the other amplifies a sequence from the endogenous mouse amylase 2.1y
gene. The PCR products from the input (I) and antibody-bound DNA (H3
and H4) were electrophoresed on a nondenaturing acrylamide gel; a
representative gel is shown. (B) Quantification of duplex PCR products
from three independent immunoprecipitation experiments. The
transgene/amylase ratio from each bound fraction was standardized by
dividing by the transgene/amylase ratio from the input material to
determine the relative enrichment of transgenic sequences during the
immunoprecipitation. The mean value and standard error of the mean for
the enrichment are plotted (see the text). The x axis is
drawn at 1, which reflects no enrichment.
|
|
In this analysis, the unmethylated and expressing clone RL5-HS2 shows
strong and comparable enrichment (17- to 22-fold) for
all three
sequences in the transgene with the antibody against
acetylated histone
H3. The antibody against acetylated histone
H4 also showed strong
enrichment (8- to 11-fold), with no detectable
difference between the
three sequences, suggesting uniform hyperacetylation
of both H4 and H3
throughout the transgene in this clone. In contrast,
the level of
enrichment for H4 and H3 in the methylated clone
RL5-HS2meth varies
among the three sequences, with the highest
level of enrichment at HS2,
an intermediate level at the promoter,
and the lowest level at the
reporter gene (Fig.
6A). A direct
comparison of the H3 acetylation
between methylated and unmethylated
constructs shows that the
methylated clone is almost twofold less
acetylated at HS2, threefold
less acetylated at the promoter,
and over sixfold less acetylated at
the gene. The extent of this
localized deacetylation directly
correlates with the CpG density,
which is highest in the GFP gene (see
Fig.
2A), indicating that
methylation density defines the degree of
local hypoacetylation.
These results are consistent with the
recruitment of HDAC-containing
complexes by MBDs and suggest that this
recruitment results in
a very localized
deacetylation.
 |
DISCUSSION |
Genomic targeting of methylated DNA results in stable
transcriptional repression.
We have targeted in vitro-methylated
DNA into the genome to analyze methylation-induced repression at
defined genomic insertion sites. DNA methylation studies have typically
utilized either nonchromosomal templates, such as transiently
transfected plasmids (2, 29), drug-selectable episomal
constructs (21), or stably integrated transgenes (12,
30). While these experiments have been informative,
nonchromosomal templates do not necessarily resemble the chromatin
structure of chromosomal DNA and thus may not accurately reflect the
effect of CpG methylation on transcription and chromatin structure.
While stable transfection results in chromosomal integration, current
protocols do not allow for control of the copy number or integration
site, and thus different constructs are analyzed in different
chromosomal contexts. Variable effects of different integration sites
on transcription and chromatin structure are well documented (13,
20), complicating the analysis of cell lines harboring stably
transfected reporter constructs. The Cre-RMCE targeting strategy
described here circumvents these limitations, permitting the stable
introduction of unmethylated and in vitro-methylated DNA at the same
integration site.
The construct we analyzed contains the GFP reporter gene driven by the
human

-globin promoter and the HS2 enhancer element
from the human

-globin locus control region. This plasmid was
either unmethylated
or methylated in vitro at all CpGs using the
bacterial
methyltransferase
SssI and introduced with similar high
efficiency into two defined genomic integration sites that support
stable expression from an unmethylated transgene. While the
unmethylated
construct is stably expressed even after long-term passage
in
culture, in vitro methylation of the reporter results in strongly
reduced expression at either integration site (Fig.
1C), suggesting
that the methylation is maintained and is responsible for this
repression.
Methylation of the transgene does not alter the methylation state,
chromatin structure, or replication timing of flanking DNA.
Consistent with the active expression state of the unmethylated
transgene over time, we find no de novo methylation of this construct.
On the other hand repression of the in vitro-methylated transgene is
stable, a result consistent with the maintenance of its methylation at
the promoter and the reporter gene. It has been proposed that spreading
of methylation in cis into nonmethylated DNA is one
mechanism by which de novo methylation occurs (50); however,
we do not observe de novo methylation in the genomic DNA adjacent to
the methylated construct. In addition, a DNase I-hypersensitive site
flanking one of the insertion sites is present independent of the
methylation state of the transgene. These observations suggest that the
introduced patch of methylated DNA at the promoter and gene is
propagated through cell division but is not sufficient to cause de novo
methylation or to alter the chromatin structure of flanking DNA.
At many loci, replication timing is correlated with transcriptional
activity; expressed loci are early replicating and silent
loci are late
replicating (
15). Since transcriptional activators
may be
limited in late S phase, late replication itself may play
a role in
gene repression (reviewed in reference
48). As would
be
predicted, the active unmethylated constructs are early replicating.
Surprisingly, at both genomic sites, the silent, in vitro-methylated
constructs are also early replicating, indicating that a change
in
replication timing to late S phase is neither a requirement
for, nor a
consequence of, methylation-induced repression at these
genomic loci.
The maintenance methylase DNMT1, which preferentially
binds to
hemimethylated DNA, was recently reported to be associated
with HDACs
(
14,
44) at replication foci. This interaction
may ensure
that, independent of the timing of replication, even
hemimethylated DNA
is in a repressive chromatin
state.
Taken together, the lack of methylation spreading, the preservation of
early replication timing, and the presence of a flanking
HS after
integration of the methylated construct suggest that
transcriptional
repression is not due to widespread changes in
the activity or
structure of the locus per se but rather to the
local effects of
methylation on the transgene
itself.
Methylation-induced repression of transcriptional initiation is
dominant over a demethylated and remodeled enhancer.
Analysis of
the methylation status of the transgenes by bisulfite sequencing
reveals that methylation at the promoter and gene is maintained over
time, whereas the enhancer is demethylated after integration of the in
vitro-methylated construct. Previous reports suggest that the binding
of transactivators to DNA can interfere with the maintenance of
methylation, probably by masking the CpG dinucleotide after DNA
replication (22, 35). Thus, the observed demethylation at
the enhancer could be a consequence of transcription factor binding to
the enhancer.
Given the demethylated state of the enhancer, it is perhaps not
surprising that the enhancer HS still forms (Fig.
3). Since
HS
formation requires non-histone protein binding (
3), the
enhancer of the methylated construct is occupied despite its close
proximity to a high density of methylated CpGs. Nevertheless,
this is
not sufficient to overcome methylation-induced repression,
and we
conclude that methylation-induced repression does not result
from
inhibition of transcription factor binding at the enhancer.
In
contrast, the methylation is maintained over the promoter and
gene and
the promoter HS does not form. Consequently, the promoter
and/or gene
are the sites at which the methylation-induced repression
mechanism
operates.
To directly address whether polymerase loading or elongation are
effected by DNA methylation, we used the nuclear run-on assay
and
measured the density of polymerases on the unmethylated and
methylated
transgenes. Previous studies using in vitro-methylated
DNA containing
mammalian promoters injected into
Xenopus oocytes
(
29) suggest that methylation results in a block to
transcription
initiation. In contrast, experiments in
N. crassa suggest that
a block to transcriptional elongation is the
major mechanism for
methylation-induced repression in this organism
(
45). Our results
indicate that, on a chromosomal template
in mammalian cells, methylation
interferes with transcriptional
initiation. However, we cannot
rule out that methylation has an
additional effect on transcriptional
elongation, since such an effect
would be masked by the repressed
initiation.
Is localized deacetylation of histones sufficient for
repression?
Two mechanisms of methylation-induced transcriptional
repression have been proposed. The binding of a subset of transcription factors is sensitive to methylation of their cognate binding sites (23), suggesting that CpG methylation of a promoter could
directly block transactivator binding. However, a direct block of
binding is unlikely to be responsible for the repression of the
-globin promoter used in this study, as the 120-bp element upstream
of the initiation site does not contain any CpGs (Fig. 2B), yet is sufficient for promoter activity (reference 36 and
references therein). An alternative mechanism of transcriptional
repression involving the MBD family of proteins has been proposed
(reviewed in reference 1). These proteins interact with,
or are integral components of, complexes which include HDACs (27,
38, 39, 51, 53), suggesting that recruitment of HDAC activity,
resulting in a modified nucleosomal structure, is a common motif in
methylation-induced repression. Accordingly, it has been shown that
methylated transgenes are hypoacetylated (6, 8, 12, 42).
Here, we observe a reduction of histone acetylation at the promoter and
gene of the in vitro-methylated transgene. The degree of deacetylation is more prominent for histone H3 than for H4 and correlates with the
density of methylated CpGs: the GFP gene, which has a high density of
CpGs, is the most hypoacetylated, while the promoter and enhancer, with
lower densities, are acetylated to a lesser extent. This localized
deacetylation suggests that the recruited HDACs act only on nearby
nucleosomes, a result consistent with that reported for the HDAC
activity of the yeast Sin3A complex (28).
In several studies treatment with the HDAC inhibitor trichostatin A
(TSA) partially relieved the transcriptional repression
of in
vitro-methylated constructs (
6,
8), whereas in others
no
reactivation was observed (
34,
41). Here, TSA treatment
of
cells containing the inactive, methylated transgene did not
result in
reactivation of reporter gene transcription (data not
shown), a result
consistent with our previous study in MEL cells
showing that a densely
methylated provirus containing the same
reporter gene could not be
reactivated by TSA alone (
34). Since
the HDACs currently
known to be involved in methylation-induced
repression are at least
partially sensitive to TSA treatment,
we speculated that a lack of
reactivation indicates an additional
HDAC independent mode of
repression (
34). However, the recent
finding that the HDAC
activity of yeast SIR2 (
24) and yeast
HOS3 (
5) is
not inhibited by TSA indicates that TSA does not
inhibit all HDAC
activity, and it remains to be determined if
methylation-induced
repression involves a TSA-resistant HDAC
activity.
Together, our experiments show that DNA methylation results in a
localized histone deacetylation without affecting the chromatin
structure and replication timing of the insertion site. Previously,
we
have shown that the transcriptionally active

-globin promoter
in its
native location is hyperacetylated (
46), and we speculated
that this hyperacetylation is required for activation. Thus, a
localized hypoacetylation mediated by CpG methylation may be sufficient
to account for the observed
repression.
 |
ACKNOWLEDGMENTS |
This work was supported by a fellowship from the Deutsche
Forschungsgemeinschaft to D.S.; NIH fellowship GM 19767/01 to M.C.L.; a
fellowship from the American Cancer Society to D.M.C.; and NIH grants
HL38655, DK56845, and HL554350 to E.E.B. and grants DK44746, HL57620,
and CA54337 to M.G.
We thank Jürgen Bode, Steven Fiering, Ross Hardison, Anton Krumm,
and the members of the Groudine lab for helpful suggestions; Claire
Francastel for helpful comments on the manuscript; and Joan Hamilton,
David Scalzo, Jennifer Stout, and Urszula Maliszewski for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. N, A3-025, Seattle, WA
98109. Phone: (206) 667-4497. Fax: (206) 667-5894. E-mail:
markg{at}fhcrc.org.
Present address: Myriad Genetics, Salt Lake City, UT 84108.
 |
REFERENCES |
| 1.
|
Bird, A. P., and A. P. Wolffe.
1999.
Methylation-induced repression belts, braces, and chromatin.
Cell
99:451-454[CrossRef][Medline].
|
| 2.
|
Boyes, J., and A. Bird.
1992.
Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein.
EMBO J.
11:327-333[Medline].
|
| 3.
|
Boyes, J., and G. Felsenfeld.
1996.
Tissue-specific factors additively increase the probability of the all-or-none formation of a hypersensitive site.
EMBO J.
15:2496-2507[Medline].
|
| 4.
|
Brandeis, M.,
M. Ariel, and H. Cedar.
1993.
Dynamics of DNA methylation during development.
Bioessays
15:709-713[CrossRef][Medline].
|
| 5.
|
Carmen, A. A.,
P. R. Griffin,
J. R. Calaycay,
S. E. Rundlett,
Y. Suka, and M. Grunstein.
1999.
Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity.
Proc. Natl. Acad. Sci. USA
96:12356-12361[Abstract/Free Full Text].
|
| 6.
|
Chen, W. Y., and T. M. Townes.
2000.
Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation.
Proc. Natl. Acad. Sci. USA
97:377-382[Abstract/Free Full Text].
|
| 7.
|
Cimbora, D. M.,
D. Schübeler,
A. Reik,
J. Hamilton,
C. Francastel,
E. M. Epner, and M. Groudine.
2000.
Long-distance control of origin choice and replication timing in the human beta-globin locus are independent of the locus control region.
Mol. Cell. Biol.
20:5581-5591[Abstract/Free Full Text].
|
| 8.
|
Eden, S.,
T. Hashimshony,
I. Keshet,
H. Cedar, and A. W. Thorne.
1998.
DNA methylation models histone acetylation.
Nature
394:842[CrossRef][Medline].
|
| 9.
| Feng, Y. Q., M. C. Lorincz, S. Fiering,
J. M. Greally, and E. Bouhassira. Position effects are
influenced by the orientation of a transgene with respect to flanking
chromatin. Mol. Cell. Biol., in press.
|
| 10.
|
Feng, Y. Q.,
J. Seibler,
R. Alami,
A. Eisen,
K. A. Westerman,
P. Leboulch,
S. Fiering, and E. E. Bouhassira.
1999.
Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange.
J. Mol. Biol.
292:779-785[CrossRef][Medline].
|
| 11.
|
Forrester, W. C.,
E. Epner,
M. C. Driscoll,
T. Enver,
M. Brice,
T. Papayannopoulou, and M. Groudine.
1990.
A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus.
Genes Dev.
4:1637-1649[Abstract/Free Full Text].
|
| 12.
|
Forrester, W. C.,
L. A. Fernandez, and R. Grosschedl.
1999.
Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions.
Genes Dev.
13:3003-3014[Abstract/Free Full Text].
|
| 13.
|
Francastel, C.,
M. C. Walters,
M. Groudine, and D. I. Martin.
1999.
A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatin.
Cell
99:259-269[CrossRef][Medline].
|
| 14.
|
Fuks, F.,
W. A. Burgers,
A. Brehm,
L. Hughes-Davies, and T. Kouzarides.
2000.
DNA methyltransferase Dnmt1 associates with histone deacetylase activity.
Nat. Genet.
24:88-91[CrossRef][Medline].
|
| 15.
|
Goldman, M. A.,
G. P. Holmquist,
M. C. Gray,
L. A. Caston, and A. Nag.
1984.
Replication timing of genes and middle repetitive sequences.
Science
224:686-692[Abstract/Free Full Text].
|
| 16.
|
Groudine, M.,
M. Peretz, and H. Weintraub.
1981.
Transcriptional regulation of hemoglobin switching in chicken embryos.
Mol. Cell. Biol.
1:281-288[Abstract/Free Full Text].
|
| 17.
|
Gu, H.,
Y. R. Zou, and K. Rajewsky.
1993.
Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.
Cell
73:1155-1164[CrossRef][Medline].
|
| 18.
|
Hendrich, B.
2000.
Methylation moves into medicine.
Curr. Biol.
10:R60-R63[CrossRef][Medline].
|
| 19.
|
Hendrich, B., and A. Bird.
1998.
Identification and characterization of a family of mammalian methyl-CpG binding proteins.
Mol. Cell. Biol.
18:6538-6547[Abstract/Free Full Text].
|
| 20.
|
Henikoff, S.
1992.
Position effect and related phenomena.
Curr. Opin. Genet. Dev.
2:907-912[CrossRef][Medline].
|
| 21.
|
Hsieh, C. L.
1994.
Dependence of transcriptional repression on CpG methylation density.
Mol. Cell. Biol.
14:5487-5494[Abstract/Free Full Text].
|
| 22.
|
Hsieh, C. L.
1999.
Evidence that protein binding specifies sites of DNA demethylation.
Mol. Cell. Biol.
19:46-56[Abstract/Free Full Text].
|
| 23.
|
Iguchi-Ariga, S. M., and W. Schaffner.
1989.
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation.
Genes Dev.
3:612-619[Abstract/Free Full Text].
|
| 24.
|
Imai, S.,
C. M. Armstrong,
M. Kaeberlein, and L. Guarente.
2000.
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
Nature
403:795-800[CrossRef][Medline].
|
| 25.
|
Jaenisch, R.
1997.
DNA methylation and imprinting: why bother?
Trends Genet.
13:323-329[CrossRef][Medline].
|
| 26.
|
Jones, P. A., and P. W. Laird.
1999.
Cancer epigenetics comes of age.
Nat. Genet.
21:163-167[CrossRef][Medline].
|
| 27.
|
Jones, P. L.,
G. J. Veenstra,
P. A. Wade,
D. Vermaak,
S. U. Kass,
N. Landsberger,
J. Strouboulis, and A. P. Wolffe.
1998.
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
Nat. Genet.
19:187-191[CrossRef][Medline].
|
| 28.
|
Kadosh, D., and K. Struhl.
1998.
Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo.
Mol. Cell. Biol.
18:5121-5127[Abstract/Free Full Text].
|
| 29.
|
Kass, S. U.,
N. Landsberger, and A. P. Wolffe.
1997.
DNA methylation directs a time-dependent repression of transcription initiation.
Curr. Biol.
7:157-165[CrossRef][Medline].
|
| 30.
|
Keshet, I.,
J. Lieman-Hurwitz, and H. Cedar.
1986.
DNA methylation affects the formation of active chromatin.
Cell
44:535-543[CrossRef][Medline].
|
| 31.
|
Krumm, A.,
L. B. Hickey, and M. Groudine.
1995.
Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.
Genes Dev.
9:559-572[Abstract/Free Full Text].
|
| 32.
|
Krumm, A.,
T. Meulia, and M. Groudine.
1993.
Common mechanisms for the control of eukaryotic transcriptional elongation.
Bioessays
15:659-665[CrossRef][Medline].
|
| 33.
|
Li, E.,
T. H. Bestor, and R. Jaenisch.
1992.
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.
Cell
69:915-926[CrossRef][Medline].
|
| 34.
|
Lorincz, M. C.,
D. Schübeler,
S. C. Goeke,
M. Walters,
M. Groudine, and D. I. Martin.
2000.
Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression.
Mol. Cell. Biol.
20:842-850[Abstract/Free Full Text].
|
| 35.
|
Matsuo, K.,
J. Silke,
O. Georgiev,
P. Marti,
N. Giovannini, and D. Rungger.
1998.
An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA.
EMBO J.
17:1446-1453[CrossRef][Medline].
|
| 36.
|
Myers, R. M.,
K. Tilly, and T. Maniatis.
1986.
Fine structure genetic analysis of a beta-globin promoter.
Science
232:613-618[Abstract/Free Full Text].
|
| 37.
|
Nan, X.,
R. R. Meehan, and A. Bird.
1993.
Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
Nucleic Acids Res.
21:4886-4892[Abstract/Free Full Text].
|
| 38.
|
Nan, X.,
H. H. Ng,
C. A. Johnson,
C. D. Laherty,
B. M. Turner,
R. N. Eisenman, and A. Bird.
1998.
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
Nature
393:386-389[CrossRef][Medline].
|
| 39.
|
Ng, H. H.,
Y. Zhang,
B. Hendrich,
C. A. Johnson,
B. M. Turner,
H. Erdjument-Bromage,
P. Tempst,
D. Reinberg, and A. Bird.
1999.
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.
Nat. Genet.
23:58-61[Medline].
|
| 40.
|
Orlando, V.,
H. Strutt, and R. Paro.
1997.
Analysis of chromatin structure by in vivo formaldehyde cross-linking.
Methods
11:205-214[CrossRef][Medline].
|
| 41.
|
Osborne, C. S.,
P. Pasceri,
R. Singal,
T. Sukonnik,
G. D. Ginder, and J. Ellis.
1999.
Amelioration of retroviral vector silencing in locus control region beta-globin-transgenic mice and transduced F9 embryonic cells.
J. Virol.
73:5490-5496[Abstract/Free Full Text].
|
| 42.
|
Pikaart, M. J.,
F. Recillas-Targa, and G. Felsenfeld.
1998.
Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators.
Genes Dev.
12:2852-2862[Abstract/Free Full Text].
|
| 43.
|
Razin, A.
1998.
CpG methylation, chromatin structure, and gene silencing a three-way connection.
EMBO J.
17:4905-4908[CrossRef][Medline].
|
| 44.
|
Rountree, M. R.,
K. E. Bachman, and S. B. Baylin.
2000.
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.
Nat. Genet.
25:269-277[CrossRef][Medline].
|
| 45.
|
Rountree, M. R., and E. U. Selker.
1997.
DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa.
Genes Dev.
11:2383-2395[Abstract/Free Full Text].
|
| 46.
|
Schübeler, D.,
C. Francastel,
D. M. Cimbora,
A. Reik,
D. I. Martin, and M. Groudine.
2000.
Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus.
Genes Dev.
14:940-950[Abstract/Free Full Text].
|
| 47.
|
Seibler, J.,
D. Schübeler,
S. Fiering,
M. Groudine, and J. Bode.
1998.
DNA cassette exchange in ES cells mediated by Flp recombinase: an efficient strategy for repeated modification of tagged loci by marker-free constructs.
Biochemistry
37:6229-6234[CrossRef][Medline].
|
| 48.
|
Simon, I., and H. Cedar.
1996.
Temporal order of DNA replication, p. 387-408.
In
M. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 49.
|
Struhl, K.
1998.
Histone acetylation and transcriptional regulatory mechanisms.
Genes Dev.
12:599-606[Free Full Text].
|
| 50.
|
Tollefsbol, T. O., and C. A. Hutchison, III.
1997.
Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase.
J. Mol. Biol.
269:494-504[CrossRef][Medline].
|
| 51.
|
Wade, P. A.,
A. Gegonne,
P. L. Jones,
E. Ballestar,
F. Aubry, and A. P. Wolffe.
1999.
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
Nat. Genet.
23:62-66[Medline].
|
| 52.
|
Yoder, J. A.,
C. P. Walsh, and T. H. Bestor.
1997.
Cytosine methylation and the ecology of intragenomic parasites.
Trends Genet.
13:335-340[CrossRef][Medline].
|
| 53.
|
Zhang, Y.,
H. H. Ng,
H. Erdjument-Bromage,
P. Tempst,
A. Bird, and D. Reinberg.
1999.
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
Genes Dev.
13:1924-1935[Abstract/Free Full Text].
|
Molecular and Cellular Biology, December 2000, p. 9103-9112, Vol. 20, No. 24
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Maksakova, I. A., Zhang, Y., Mager, D. L.
(2009). Preferential Epigenetic Suppression of the Autonomous MusD over the Nonautonomous ETn Mouse Retrotransposons. Mol. Cell. Biol.
29: 2456-2468
[Abstract]
[Full Text]
-
Wu, Y., Starzinski-Powitz, A., Guo, S.-W.
(2007). Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells. Reproductive Sciences
14: 374-382
[Abstract]
-
Okitsu, C. Y., Hsieh, C.-L.
(2007). DNA Methylation Dictates Histone H3K4 Methylation. Mol. Cell. Biol.
27: 2746-2757
[Abstract]
[Full Text]
-
Webster, R. B., Rodriguez, Y., Klimecki, W. T., Vercelli, D.
(2007). The Human IL-13 Locus in Neonatal CD4+ T Cells Is Refractory to the Acquisition of a Repressive Chromatin Architecture. J. Biol. Chem.
282: 700-709
[Abstract]
[Full Text]
-
Searles, C. D.
(2006). Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am. J. Physiol. Cell Physiol.
291: C803-C816
[Abstract]
[Full Text]
-
Rollins, R. A., Haghighi, F., Edwards, J. R., Das, R., Zhang, M. Q., Ju, J., Bestor, T. H.
(2006). Large-scale structure of genomic methylation patterns. Genome Res
16: 157-163
[Abstract]
[Full Text]
-
Padjen, K., Ratnam, S., Storb, U.
(2005). DNA Methylation Precedes Chromatin Modifications under the Influence of the Strain-Specific Modifier Ssm1. Mol. Cell. Biol.
25: 4782-4791
[Abstract]
[Full Text]
-
Leu, Y.-W., Yan, P. S., Fan, M., Jin, V. X., Liu, J. C., Curran, E. M., Welshons, W. V., Wei, S. H., Davuluri, R. V., Plass, C., Nephew, K. P., Huang, T. H-M.
(2004). Loss of Estrogen Receptor Signaling Triggers Epigenetic Silencing of Downstream Targets in Breast Cancer. Cancer Res.
64: 8184-8192
[Abstract]
[Full Text]
-
Lee, L. T.-O., Tan-Un, K.-C., Pang, R. T.-K., Lam, D. T.-W., Chow, B. K.-C.
(2004). Regulation of the Human Secretin Gene Is Controlled by the Combined Effects of CpG Methylation, Sp1/Sp3 Ratio, and the E-Box Element. Mol. Endocrinol.
18: 1740-1755
[Abstract]
[Full Text]
-
Schubeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D. E., O'Neill, L. P., Turner, B. M., Delrow, J., Bell, S. P., Groudine, M.
(2004). The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev.
18: 1263-1271
[Abstract]
[Full Text]
-
Yusa, K., Takeda, J., Horie, K.
(2004). Enhancement of Sleeping Beauty Transposition by CpG Methylation: Possible Role of Heterochromatin Formation. Mol. Cell. Biol.
24: 4004-4018
[Abstract]
[Full Text]
-
Carvin, C. D., Parr, R. D., Kladde, M. P.
(2003). Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins. Nucleic Acids Res
31: 6493-6501
[Abstract]
[Full Text]
-
Giraldo, P., Martinez, A., Regales, L., Lavado, A., Garcia-Diaz, A., Alonso, A., Busturia, A., Montoliu, L.
(2003). Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity. Nucleic Acids Res
31: 6290-6305
[Abstract]
[Full Text]
-
Singal, R., vanWert, J. M., Ferdinand, L. Jr
(2002). Methylation of alpha -type embryonic globin gene alpha pi represses transcription in primary erythroid cells. Blood
100: 4217-4222
[Abstract]
[Full Text]
-
Lorincz, M. C., Schubeler, D., Hutchinson, S. R., Dickerson, D. R., Groudine, M.
(2002). DNA Methylation Density Influences the Stability of an Epigenetic Imprint and Dnmt3a/b-Independent De Novo Methylation. Mol. Cell. Biol.
22: 7572-7580
[Abstract]
[Full Text]
-
Irvine, R. A., Lin, I. G., Hsieh, C.-L.
(2002). DNA Methylation Has a Local Effect on Transcription and Histone Acetylation. Mol. Cell. Biol.
22: 6689-6696
[Abstract]
[Full Text]
-
Harju, S., McQueen, K. J., Peterson, K. R.
(2002). Chromatin Structure and Control of {beta}-Like Globin Gene Switching. Exp. Biol. Med.
227: 683-700
[Abstract]
[Full Text]
-
Dumont, J. E., Dremier, S., Pirson, I., Maenhaut, C.
(2002). Cross signaling, cell specificity, and physiology. Am. J. Physiol. Cell Physiol.
283: C2-C28
[Abstract]
[Full Text]
-
Mutskov, V. J., Farrell, C. M., Wade, P. A., Wolffe, A. P., Felsenfeld, G.
(2002). The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation. Genes Dev.
16: 1540-1554
[Abstract]
[Full Text]
-
El-Osta, A., Kantharidis, P., Zalcberg, J. R., Wolffe, A. P.
(2002). Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation. Mol. Cell. Biol.
22: 1844-1857
[Abstract]
[Full Text]
-
Stimson, K. M., Vertino, P. M.
(2002). Methylation-mediated Silencing of TMS1/ASC Is Accompanied by Histone Hypoacetylation and CpG Island-localized Changes in Chromatin Architecture. J. Biol. Chem.
277: 4951-4958
[Abstract]
[Full Text]
-
Lorincz, M. C., Schubeler, D., Groudine, M.
(2001). Methylation-Mediated Proviral Silencing Is Associated with MeCP2 Recruitment and Localized Histone H3 Deacetylation. Mol. Cell. Biol.
21: 7913-7922
[Abstract]
[Full Text]
-
Viollet, B., Yaniv, M., Pontoglio, M.
(2001). Embryonic but Not Postnatal Reexpression of Hepatocyte Nuclear Factor 1{alpha} (HNF1{alpha}) Can Reactivate the Silent Phenylalanine Hydroxylase Gene in HNF1{alpha}-Deficient Hepatocytes. Mol. Cell. Biol.
21: 3662-3670
[Abstract]
[Full Text]
-
Singal, R., Wang, S. Z., Sargent, T., Zhu, S. Z., Ginder, G. D.
(2002). Methylation of Promoter Proximal-transcribed Sequences of an Embryonic Globin Gene Inhibits Transcription in Primary Erythroid Cells and Promotes Formation of a Cell Type-specific Methyl Cytosine Binding Complex. J. Biol. Chem.
277: 1897-1905
[Abstract]
[Full Text]